Treatment of Hypertension in Obese Patients: Focus on Telmisartan

Cardiovascular Therapy and Prevention (Russian Federation) - Russian Federation
doi 10.15829/1728-8800-2018-6-69-76
Full Text
Abstract

Available in full text

Date
Authors
Publisher

Silicea - Poligraf, LLC

Related search

Telmisartan in the Treatment of Hypertension in Patients With Chronic Renal Insufficiency

Biomedical papers of the Medical Faculty of the University Palacky, Olomouc, Czechoslovakia
BiochemistryMedicineGeneticsMolecular Biology
2004English

Telmisartan in the Hypertension Treatment: From Pharmacological Characteristics to Clinical Benefits

Cardiovascular Therapy and Prevention (Russian Federation)
Cardiovascular MedicineCardiology
2020English

Pharmacotherapy of Arterial Hypertension in Elderly Patients: Focus on Octogenarians

Rational Pharmacotherapy in Cardiology
Cardiovascular MedicinePharmacologyCardiology
2016English

A Focus on Macitentan in the Treatment of Pulmonary Arterial Hypertension

Basic and Clinical Pharmacology and Toxicology
MedicineToxicologyPharmacology
2018English

A Focus on Riociguat in the Treatment of Pulmonary Arterial Hypertension

Basic and Clinical Pharmacology and Toxicology
MedicineToxicologyPharmacology
2019English

Focus on Prevention, Diagnosis and Treatment of Hypertension in Children and Adolescents

Italian Journal of Pediatrics
Child HealthPediatricsPerinatology
2013English

An Update on the Treatment of Osteoarthritis in Obese Patients

Expert Opinion on Pharmacotherapy
MedicinePharmacology
2016English

Influence of Additional Risk Factors on the Antihypertensive Efficacy of Eprosartan and Telmisartan in Patients With Essential Hypertension

Pathologia
2017English

Treatment of Pediatric Pulmonary Arterial Hypertension: A Focus on the NO‐sGC‐cGMP Pathway

Pediatric Pulmonology
Child HealthPulmonaryPediatricsPerinatologyRespiratory Medicine
2019English

Amanote Research

Note-taking for researchers

Follow Amanote

© 2024 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy